Latest California Healthline Stories
Dying Patients With Rare Diseases Struggle to Get Experimental Therapies
When patients with common terminal illnesses such as cancer seek permission for compassionate use of therapies in the testing stage, their requests often are approved. But those with more unusual illnesses say drug companies are rarely willing to provide access.
Teen Volunteers Get a Foot in the Door for Nursing Home Careers
A group of New York senior living facilities offer teens from 10 underserved schools the chance to volunteer and get free training for entry-level health jobs, career coaching and assistance on college prep.
Adolescentes voluntarios se abren paso como futuros profesionales en hogares de adultos mayores
Desde que se puso en marcha en 2006, el programa de desarrollo para la carrera en geriatría ha ayudado a más de 700 estudiantes de secundaria de 10 escuelas de bajos recursos, en la ciudad de Nueva York, a adquirir experiencia práctica en cuidados geriátricos.
Federal Speech Rulings May Embolden Health Care Workers to Call Out Safety Issues
Policies mandating company approval before talking publicly about conditions in hospitals have been a source of conflict over the past year, as physicians, nurses and other health workers have been disciplined for speaking or posting about what they view as dangerous covid-19 safety precautions. The appeals court’s decision could mean that hospitals — and other employers — will need to revise their policies.
Effort to Decipher Hospital Prices Yields Key Finding: Don’t Try It at Home
Your dutiful columnist tried to make use of a federal “transparency” rule to compare the prices of common medical procedures in two California health care systems. It was a futile exercise.
Drugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Say
The pharmaceutical industry argues that large profits are needed to fund extensive research and innovation. But Democrats on the House Oversight and Reform Committee, seeking to bolster their effort to let Medicare negotiate drug prices, say major drug companies plow more of their billions in earnings back into propping up their stock and enriching executives and shareholders.
KHN’s ‘What the Health?’: Un-Trumping the ACA
The Biden administration is moving to undo many of the changes the Trump administration made to the enrollment process for the Affordable Care Act, in an effort to encourage more people to sign up for health insurance. Meanwhile, Congress is opening investigations into the controversial approval by the Food and Drug Administration of an expensive new drug that might or might not slow the progression of Alzheimer’s disease. Joanne Kenen of Politico, Kimberly Leonard of Insider and Sarah Karlin-Smith of The Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Marshall Allen of ProPublica about his new book, “Never Pay the First Bill: And Other Ways to Fight the Health Care System and Win.”
A Hospital Charged $722.50 to Push Medicine Through an IV. Twice.
A college student never got an answer for what caused her intense pain, but she did get a bill that totaled $18,736 for an ER visit. She and her mom, a nurse practitioner, fought to understand all the charges.
Covid’s Lingering Effects Can Put the Brakes on Elective Surgeries
Even after recovering from covid, many patients experience respiratory or other problems and, since this effect of the virus is so unpredictable, medical experts aren’t sure when it is safe to undergo elective surgery. But medical experts are setting up guidelines.
No Vacancy: How a Shortage of Mental Health Beds Keeps Kids Trapped Inside ERs
What’s known as emergency room boarding of psychiatric patients has risen between 200% and 400% monthly in Massachusetts during the pandemic — and the problem is widespread. The CDC says emergency room visits after suicide attempts among teen girls were up 51% earlier this year as compared with 2019.